Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

Next Previous
Search
Trial Profile

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 08 Jan 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Triamcinolone (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Registrational; Therapeutic Use
  • Sponsors Flexion Therapeutics; Pacira BioSciences

    • Most Recent Events

    • 07 Nov 2019 According to a Flexion Therapeutics media release, the company previously announced that this trial was paused due to a non-safety related issue which resulted in the inability to deliver a full dose in a small number of trial participants. In November, the Company determined that an exploratory study designed to resolve the issue was unsuccessful, and as a result, the Company made the decision to discontinue this trial.
    • 07 Nov 2019 Status changed from active, no longer recruiting to discontinued, due to inability to deliver a full dose in a small number of trial participants, according to a Flexion Therapeutics media release.
    • 07 Jun 2019 Planned End Date changed from 31 Aug 2020 to 30 Dec 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top